• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

欧洲 48061 例消化道癌患者中慢性阻塞性肺疾病的患病率。

Prevalence of chronic obstructive pulmonary disease among 48,061 digestive tract cancer patients in Europe.

机构信息

Clinic for Gastroenterology, Hepatology and Infectious Diseases, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Epidemiology, IQVIA, Frankfurt, Germany.

出版信息

Ann Palliat Med. 2022 Sep;11(9):2813-2818. doi: 10.21037/apm-22-200. Epub 2022 Aug 10.

DOI:10.21037/apm-22-200
PMID:35948471
Abstract

BACKGROUND

Chronic obstructive pulmonary disease (COPD) shares common risk factors with digestive tract malignancies such as esophageal cancer. However, the prevalence and geographic distribution of COPD in patients with gastrointestinal (GI) cancer is only poorly understood.

METHODS

We used the IQVIA's Oncology Dynamics (OD) database to identify a total of 48,061 patients with GI cancer (4,229 esophagus, 7,568 stomach, 27,300 colon, and 8,964 rectum cancer) from Germany, France, Italy, Spain and the UK.

RESULTS

The prevalence of COPD among the 48,061 patients with GI cancer was 12.5% (5,983/48,061). We observed significant differences in frequencies of COPD between the different cancer sites with the highest COPD prevalence among patients with esophageal (25.5%) or gastric cancer (13.4%) and lowest prevalence in colon (11.0%) or rectal (9.8%) cancer patients. Moreover, rates of COPD strongly varied between digestive tract cancer patients from different countries. Interestingly, Spain (16.8%) and Germany (13.4%) had the highest COPD prevalence while prevalence of COPD was lowest in the UK (8.4%). Finally, we showed that the proportion of digestive tract cancer patients with COPD was highest among male patients (15%) and those >80 years (20.6%) when compared to all other patients.

CONCLUSIONS

In this analysis, we show that COPD is found at high frequencies in patients with digestive tract cancer in Europe. We demonstrate that prevalence varies according to digestive tract cancer sites and European countries.

摘要

背景

慢性阻塞性肺疾病(COPD)与食管癌等消化道恶性肿瘤有共同的危险因素。然而,胃肠道(GI)癌症患者中 COPD 的患病率和地理分布情况知之甚少。

方法

我们使用 IQVIA 的肿瘤动力学(OD)数据库,从德国、法国、意大利、西班牙和英国共确定了 48061 例 GI 癌症(4229 例食管癌、7568 例胃癌、27300 例结肠癌和 8964 例直肠癌)患者。

结果

48061 例 GI 癌症患者中 COPD 的患病率为 12.5%(5983/48061)。我们观察到不同癌症部位之间 COPD 的患病率存在显著差异,食管癌(25.5%)或胃癌(13.4%)患者的 COPD 患病率最高,结肠癌(11.0%)或直肠癌(9.8%)患者的患病率最低。此外,不同国家的消化道癌患者的 COPD 发生率差异很大。有趣的是,西班牙(16.8%)和德国(13.4%)的 COPD 患病率最高,而英国的 COPD 患病率最低(8.4%)。最后,我们发现与所有其他患者相比,男性患者(15%)和>80 岁的患者(20.6%)中患有 COPD 的消化道癌患者比例最高。

结论

在这项分析中,我们表明 COPD 在欧洲的消化道癌症患者中发病率较高。我们证明了患病率根据消化道癌症部位和欧洲国家而有所不同。

相似文献

1
Prevalence of chronic obstructive pulmonary disease among 48,061 digestive tract cancer patients in Europe.欧洲 48061 例消化道癌患者中慢性阻塞性肺疾病的患病率。
Ann Palliat Med. 2022 Sep;11(9):2813-2818. doi: 10.21037/apm-22-200. Epub 2022 Aug 10.
2
Prevalence of diabetes mellitus among 80,193 gastrointestinal cancer patients in five European and three Asian countries.80193 名来自五个欧洲国家和三个亚洲国家的胃肠道癌患者中糖尿病的患病率。
J Cancer Res Clin Oncol. 2022 May;148(5):1057-1062. doi: 10.1007/s00432-021-03861-7. Epub 2021 Dec 12.
3
Analyses of sex-based clinicopathological differences among patients with gastrointestinal neuroendocrine neoplasms in Europe.欧洲胃肠道神经内分泌肿瘤患者基于性别的临床病理差异分析。
J Cancer Res Clin Oncol. 2023 Aug;149(10):7557-7563. doi: 10.1007/s00432-023-04711-4. Epub 2023 Mar 27.
4
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.意大利癌症数据——2015年报告:意大利罕见癌症的负担
Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035.
5
Epidemiology of chronic obstructive pulmonary disease: a literature review.慢性阻塞性肺疾病的流行病学:文献综述。
Int J Chron Obstruct Pulmon Dis. 2012;7:457-94. doi: 10.2147/COPD.S32330. Epub 2012 Jul 20.
6
Prevalence of and factors associated with a treatment delay due to the COVID-19 pandemic in patients with gastrointestinal cancer in Europe.欧洲胃肠道癌症患者因 COVID-19 大流行而导致治疗延误的流行情况和相关因素。
J Cancer Res Clin Oncol. 2023 Oct;149(13):11849-11856. doi: 10.1007/s00432-023-05062-w. Epub 2023 Jul 6.
7
Differences in place of death between lung cancer and COPD patients: a 14-country study using death certificate data.肺癌和 COPD 患者死亡地点的差异:使用死亡证明数据的 14 国研究。
NPJ Prim Care Respir Med. 2017 Mar 3;27(1):14. doi: 10.1038/s41533-017-0017-y.
8
Geographic variations of the prevalence and distribution of COPD phenotypes in Spain: "the ESPIRAL-ES study".西班牙慢性阻塞性肺疾病(COPD)表型患病率及分布的地理差异:“ESPIRAL-ES研究”
Int J Chron Obstruct Pulmon Dis. 2018 Apr 10;13:1115-1124. doi: 10.2147/COPD.S158031. eCollection 2018.
9
Recommendations for COPD management in Central and Eastern Europe.慢性阻塞性肺疾病管理在中东欧的建议。
Expert Rev Respir Med. 2022 Feb;16(2):221-234. doi: 10.1080/17476348.2021.2023498. Epub 2022 Feb 3.
10
Prevalence of Lung Metastases among 19,321 Metastatic Colorectal Cancer Patients in Eight Countries of Europe and Asia.欧洲和亚洲八个国家 19321 例转移性结直肠癌患者肺转移的发生率。
Curr Oncol. 2021 Nov 30;28(6):5035-5040. doi: 10.3390/curroncol28060423.

引用本文的文献

1
Relative Survival, Conditional Survival, and Causes of Death in Patients with Early Gastric Cancer, with a Focus on Differences Between Cardia and Non-Cardia Cancer.早期胃癌患者的相对生存率、条件生存率及死亡原因,重点关注贲门癌与非贲门癌之间的差异。
Cancers (Basel). 2024 Dec 21;16(24):4262. doi: 10.3390/cancers16244262.
2
Measurement and optimization of perioperative risk among patients undergoing surgery for esophageal cancer.测量和优化食管癌手术患者的围手术期风险。
Dis Esophagus. 2024 Feb 29;37(3). doi: 10.1093/dote/doad062.
3
Causes of Death Following Gastric Cancer Diagnosis: A Population-Based Analysis.
胃癌诊断后的死因分析:基于人群的研究。
Med Sci Monit. 2023 May 23;29:e939848. doi: 10.12659/MSM.939848.
4
Analyses of sex-based clinicopathological differences among patients with gastrointestinal neuroendocrine neoplasms in Europe.欧洲胃肠道神经内分泌肿瘤患者基于性别的临床病理差异分析。
J Cancer Res Clin Oncol. 2023 Aug;149(10):7557-7563. doi: 10.1007/s00432-023-04711-4. Epub 2023 Mar 27.